BNBX · Categories · M&A
BNBX - Mergers and acquisitions
BNB Plus Corp. (BNBX) mergers and acquisitions - real-time wire coverage filtered to M&A only.
Recent M&A for BNBX
- BNB Plus Provides BNB Treasury and Operational UpdatesCompany Acquires 3,349 Additional BNB Tokens LineaRx Subsidiary Expected to Narrow Losses and Approach Profitability in FY26Q1 Company Launches New Corporate Website and Branding BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today provided a corporate update highlighting its recent strategic treasury growth, expected significant narrowing of losses at its LineaRx, Inc. ("LineaRx") subsidiary, and the launch of a new corporate website and branding. Significant Addition to BNB Treasury The Company has opportunistically deployed an additional approximately $3 million to acquire additional BNB tokens at an average price of approximately $895 per token, further strengthening the C
- BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate UpdateCompany Launches BNBX.io to Provide Robust Real-Time Portfolio and Company Metrics Company Recently Closed Up to $58 Million Private Placement to Launch Yield-Focused BNB Treasury Applied DNA Sciences, Inc. (NASDAQ:BNBX) ( "BNBX" or the "Company") today announced the launch of BNBX.io, which provides real-time portfolio metrics updating the market on the Company's BNB treasury holdings, key valuation metrics, and detailed information about the capitalization structure of the Company (the "Dashboard"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028565774/en/ "The launch of our Dashboard reflects BNBX's commitment to re
- Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 MillionCompany Officially Launches Yield-Focused Digital Asset Treasury Strategy Streamlines Operations, Achieving Approximately $2.9 Million in Annualized Cost Savings Applied DNA Sciences, Inc. (NASDAQ:BNBX) ("Applied DNA", "BNBX" or the "Company"), a biotechnology company advancing a yield focused BNB digital asset treasury strategy and commercializing nucleic acid production solutions, today announced the successful close of its previously announced private investment in public equity ("PIPE") financing led by institutional DeFi and TradFi investors. The PIPE resulted in gross proceeds of approximately $27 Million to the Company, before deducting placement agent fees and other offering e